A number of recent studies have shown the involvement of NUSAP1 in cancer and have explored its mechanism of action in various diseases, including glioblastoma [9], bladder cancer [10], nasopharyngeal carcinoma [11], non-small-cell lung cancer [12], liver cancer [13], osteosarcoma [14], ovarian cancer [15], breast cancer [16], and gastric cancer [17]. This evidence concerns the gene NUSAP1 and nasopharyngeal carcinoma.